Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
| Status: | Terminated |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/1/2019 |
| Start Date: | January 2005 |
| End Date: | January 2006 |
A Randomized, Multi-center, Double-blind, Placebo Controlled, Dose Ranging Study With VSL#3 in Diarrhea Predominant IBS Patients
To evaluate the effects of VSL#3 on symptoms associated with diarrhea predominant IBS
The study will evaluate 2 doses of VSL#3 and placebo over a 4 week period in patients
presenting with diarrhea predominant IBS symptoms.
presenting with diarrhea predominant IBS symptoms.
Inclusion Criteria:
- IBS diarrhea
Exclusion Criteria:
- < 18 years of age
- Pregnancy/breast feeding
- concomitant medications to reduce bowel function
We found this trial at
1
site
